2024 annual financial data
Cadrenal Therapeutics 2024 Operating margin
Cadrenal Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -10,960,619 USD and net income was -10,651,368 USD.
Operating cash flow was -7,357,550 USD.
Get free Cadrenal Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -10,960,619 USD
- Net income
- -10,651,368 USD
- Operating cash flow
- -7,357,550 USD